politics

UK Sets Minimum Age of 11 for Puberty Blocker Clinical Trial

19 Haziran 2026BBC News

A new clinical trial in the UK has established a minimum age of 11 for children seeking to participate in studies involving puberty-blocking drugs. This decision aims to ensure that only those who are at a certain developmental stage can access these treatments.
The trial is significant as it addresses the needs of gender-questioning youth while also considering their maturity and understanding of the implications of such medical interventions.
Puberty blockers are medications that can delay the physical changes associated with puberty, providing time for children questioning their gender identity to explore their feelings without the pressure of irreversible changes. The trial's age limit is part of a broader discussion on how best to support young people…
Setting a minimum age of 11 for participation in the puberty blocker trial reflects a cautious approach to a complex issue. It acknowledges the need for informed consent and the developmental considerations of young adolescents.

NewsAI özeti

This article is for informational purposes only and does not constitute medical advice.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.